Literature DB >> 26293766

Cardiac Fibrosis in Patients With Atrial Fibrillation: Mechanisms and Clinical Implications.

Mikhail S Dzeshka1, Gregory Y H Lip2, Viktor Snezhitskiy3, Eduard Shantsila4.   

Abstract

Atrial fibrillation (AF) is associated with structural, electrical, and contractile remodeling of the atria. Development and progression of atrial fibrosis is the hallmark of structural remodeling in AF and is considered the substrate for AF perpetuation. In contrast, experimental and clinical data on the effect of ventricular fibrotic processes in the pathogenesis of AF and its complications are controversial. Ventricular fibrosis seems to contribute to abnormalities in cardiac relaxation and contractility and to the development of heart failure, a common finding in AF. Given that AF and heart failure frequently coexist and that both conditions affect patient prognosis, a better understanding of the mutual effect of fibrosis in AF and heart failure is of particular interest. In this review paper, we provide an overview of the general mechanisms of cardiac fibrosis in AF, differences between fibrotic processes in atria and ventricles, and the clinical and prognostic significance of cardiac fibrosis in AF.
Copyright © 2015 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  cardiac; extracellular matrix; heart failure; myocytes; myofibroblasts

Mesh:

Year:  2015        PMID: 26293766     DOI: 10.1016/j.jacc.2015.06.1313

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  146 in total

1.  Right Ventricular Structure and Function Are Associated With Incident Atrial Fibrillation: MESA-RV Study (Multi-Ethnic Study of Atherosclerosis-Right Ventricle).

Authors:  Neal A Chatterjee; Ravi V Shah; Venkatesh L Murthy; Amy Praestgaard; Sanjiv J Shah; Corey E Ventetuolo; R Graham Barr; Richard Kronmal; Joao A C Lima; David A Bluemke; Michael Jerosch-Herold; Alvaro Alonso; Steven M Kawut
Journal:  Circ Arrhythm Electrophysiol       Date:  2017-01

Review 2.  Epidemiology of Atrial Fibrillation in the 21st Century: Novel Methods and New Insights.

Authors:  Jelena Kornej; Christin S Börschel; Emelia J Benjamin; Renate B Schnabel
Journal:  Circ Res       Date:  2020-06-18       Impact factor: 17.367

Review 3.  Myocardial Interstitial Fibrosis in Nonischemic Heart Disease, Part 3/4: JACC Focus Seminar.

Authors:  Javier Díez; Arantxa González; Jason C Kovacic
Journal:  J Am Coll Cardiol       Date:  2020-05-05       Impact factor: 24.094

Review 4.  Atrial cardiopathy: a mechanism of cryptogenic stroke.

Authors:  Shadi Yaghi; Hooman Kamel; Mitchell S V Elkind
Journal:  Expert Rev Cardiovasc Ther       Date:  2017-07-27

5.  Is left atrial appendage isolation a pyrrhic victory in the effort to treat atrial fibrillation?

Authors:  T Jared Bunch; John D Day
Journal:  J Thorac Dis       Date:  2017-01       Impact factor: 2.895

6.  Multiparametric assessment of left atrial remodeling using 18F-FDG PET/CT cardiac imaging: A pilot study.

Authors:  Michael Ghannam; Hong Jun Yun; Edward P Ficaro; Hamid Ghanbari; John J Lazarus; Matthew Konerman; Ravi V Shah; Richard Weinberg; James R Corbett; Hakan Oral; Venkatesh L Murthy
Journal:  J Nucl Cardiol       Date:  2018-09-06       Impact factor: 5.952

Review 7.  Cardiac aging and heart disease in humans.

Authors:  Marja Steenman; Gilles Lande
Journal:  Biophys Rev       Date:  2017-03-20

8.  Predictors of non-pulmonary vein foci in paroxysmal atrial fibrillation.

Authors:  Keita Watanabe; Junichi Nitta; Osamu Inaba; Akira Sato; Yukihiro Inamura; Nobutaka Kato; Masahito Suzuki; Masahiko Goya; Kenzo Hirao; Tetsuo Sasano
Journal:  J Interv Card Electrophysiol       Date:  2020-05-28       Impact factor: 1.900

9.  Is Otsu thresholding the answer to reproducible quantification of left atrial scar from late gadolinium-enhancement MRI?

Authors:  Suvai Gunasekaran; Daniel Kim
Journal:  J Cardiovasc Electrophysiol       Date:  2020-09-21

10.  Increased Susceptibility to Atrial Fibrillation Secondary to Atrial Fibrosis in Transgenic Goats Expressing Transforming Growth Factor-β1.

Authors:  Irina A Polejaeva; Ravi Ranjan; Christopher J Davies; Misha Regouski; Justin Hall; Aaron L Olsen; Qinggang Meng; Heloisa M Rutigliano; Derek J Dosdall; Nathan A Angel; Frank B Sachse; Thomas Seidel; Aaron J Thomas; Rusty Stott; Kip E Panter; Pamela M Lee; Arnaud J Van Wettere; John R Stevens; Zhongde Wang; Rob S MacLeod; Nassir F Marrouche; Kenneth L White
Journal:  J Cardiovasc Electrophysiol       Date:  2016-08-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.